Insulin Delivery Device Market Report: Trends, Forecast, and Competitive Analysis


Posted November 14, 2019 by shubhamverma

Trends, opportunities, and forecast in insulin delivery device market to 2024 by product type (insulin syringe, insulin pens, insulin pumps, pen needles, and other device), end user and region.

 
According to a new market report published by Lucintel, the future of the insulin delivery device market looks promising with opportunities in the patients/homecare and hospitals & clinic end use segments. The insulin delivery device market is expected to grow with a CAGR of 9% from 2019 to 2024. The major drivers for this market are growing geriatric population base, high adoption of sedentary lifestyle and growing awareness of diabetes treatment, technological advancements in insulin delivery devices, and rising awareness of advanced insulin delivery devices.
In this market, various insulin devices are used to access an insulin dose, such as insulin pens, pumps, pen needles, and syringes. Insulin pens is the largest product segment of the insulin delivery device market.
North America will remain the largest region over the forecast period due to high prevalence of the condition in the US and the high adoption rate of advanced mechanisms.
Becton Dickinson and Company, Novo Nordisk A/S, Medtronic, Sanofi, ELI Lilly and Company, Ypsomed, Animas, Tandem Diabetes Care, Insulet, and Biocon are among the major manufacturers of insulin delivery devices.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the insulin delivery device market by product type, end user, and region. Lucintel has prepared a comprehensive research report titled " Insulin Delivery Device Market 2019-2024: Trends, Forecast, and Opportunity Analysis". The Lucintel report serves as a catalyst for growth strategies, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the insulin delivery device market by product type, end user, and region as follows:
By Product Type [$M shipment analysis for 2013 – 2024]:
• Insulin Syringe
• Insulin Pens
• Insulin Pumps
• Pen Needles
• Other Devices
By End User [$M shipment analysis for 2013 – 2024]:
• Patients/Homecare
• Hospitals and Clinics
By Region [$M shipment analysis for 2013 – 2024]:
• North America
o United States
o Canada
o Mexico
• Europe
o United Kingdom
o Germany
o France
o Italy
o Spain
• Asia Pacific
o China
o India
o Japan
• ROW
o Brazil
A report of more than 150 pages will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link…… or [email protected].
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
This report addresses the following key questions:
Q.1. What are some of the most promising potential, high growth opportunities for the insulin delivery device market by product type (insulin syringe, insulin pens, insulin pumps, pen needles, and other device), end user (patients/homecare and hospitals & clinics), and region (North America, Europe, Asia-Pacific, and ROW)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which regions will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the drivers and challenges of the insulin delivery device market?
Q.5. What are the business risks and threats to the insulin delivery device market?
Q.6. What are the emerging trends in the insulin delivery device market and the reasons behind them?
Q.7. What are some changing demands of customers in the insulin delivery device market?
Q.8. What are the new developments in the insulin delivery device market? Which companies are leading these developments?
Q.9. Who are the major players in the insulin delivery device market? What strategic initiatives are being implemented by key players for business growth?
Q.10. What are some of the competitive products and processes in the insulin delivery device market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11. What M & A activities did take place in the last five years in the insulin delivery device market?
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Insulin Delivery Device Market
Phone 9726365056
Business Address Lucintel, 8951 Cypress Waters Blvd., Suite 160, Dallas, TX 75019
Country United States
Categories Advertising
Tags insulin delivery device market
Last Updated November 14, 2019